Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2013 (2013), Article ID 914053, 7 pages
http://dx.doi.org/10.1155/2013/914053
Review Article

Ductal Carcinoma In Situ: What the Pathologist Needs to Know and Why

1Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada L8V 1C3
2Department of Oncology, McMaster University, Hamilton, ON, Canada L8V 1C3

Received 6 November 2012; Revised 19 December 2012; Accepted 2 January 2013

Academic Editor: Rebecca A. Shelby

Copyright © 2013 Anita Bane. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. D. Dupont and D. L. Page, “Risk factors for breast cancer in women with proliferative breast disease,” The New England Journal of Medicine, vol. 312, no. 3, pp. 146–151, 1985. View at Google Scholar · View at Scopus
  2. V. L. Ernster, R. Ballard-Barbash, W. E. Barlow et al., “Detection of ductal carcinoma in situ in women undergoing screening mammography,” Journal of the National Cancer Institute, vol. 94, no. 20, pp. 1546–1554, 2002. View at Google Scholar · View at Scopus
  3. D. S. May, N. C. Lee, L. C. Richardson, A. G. Giustozzi, and J. K. Bobo, “Mammography and breast cancer detection by race and Hispanic ethnicity: results from a national program (United States),” Cancer Causes and Control, vol. 11, no. 8, pp. 697–705, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Kerlikowske, D. L. Miglioretti, D. S. M. Buist, R. Walker, and P. A. Carney, “Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population,” Journal of the National Cancer Institute, vol. 99, no. 17, pp. 1335–1339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C. I. Li, J. R. Daling, and K. E. Malone, “Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 4, pp. 1008–1011, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Kerlikowske, R. Walker, D. L. Miglioretti, A. Desai, R. Ballard-Barbash, and D. S. M. Buist, “Obesity, mammography use and accuracy, and advanced breast cancer risk,” Journal of the National Cancer Institute, vol. 100, no. 23, pp. 1724–1733, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Kerlikowske, D. L. Miglioretti, R. Ballard-Barbash et al., “Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population,” Journal of Clinical Oncology, vol. 21, no. 23, pp. 4314–4321, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. “The consensus conference committee. consensus conference on the classification of ductal carcinoma in situ,” Cancer, vol. 80, no. 9, pp. 1798–1802, 1997.
  9. M. J. Silverstein, D. N. Poller, J. R. Waisman et al., “Prognostic classification of breast ductal carcinoma-in-situ,” The Lancet, vol. 345, no. 8958, pp. 1154–1157, 1995. View at Google Scholar · View at Scopus
  10. R. Holland, J. L. Peterse, R. R. Millis et al., “Ductal carcinoma in situ: a proposal for a new classification,” Seminars in Diagnostic Pathology, vol. 11, no. 3, pp. 167–180, 1994. View at Google Scholar · View at Scopus
  11. M. A. Scott, M. D. Lagios, K. Axelsson, L. W. Rogers, T. J. Anderson, and D. L. Page, “Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis,” Human Pathology, vol. 28, no. 8, pp. 967–973, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. S. C. Lester, S. Bose, Y. Y. Chen et al., “Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast,” Archives of Pathology and Laboratory Medicine, vol. 133, no. 1, pp. 15–25, 2009. View at Google Scholar · View at Scopus
  13. D. C. Allred, Y. Wu, S. Mao et al., “Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution,” Clinical Cancer Research, vol. 14, no. 2, pp. 370–378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Tavassoli and P. Devilee, Pathology & Genetics. Tumours of the Breast and Female Genital Organs, IARC Press, Lyon, France, 2003.
  15. E. A. Rakha, N. Gandhi, F. Climent et al., “Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis,” American Journal of Surgical Pathology, vol. 35, no. 8, pp. 1093–1103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. O. C. Bellamy, C. McDonald, D. M. Salter, U. Chetty, and T. J. Anderson, “Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization,” Human Pathology, vol. 24, no. 1, pp. 16–23, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. F. P. O'Malley and A. Bane, “An update on apocrine lesions of the breast,” Histopathology, vol. 52, no. 1, pp. 3–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. F. P. O'Malley and A. L. Bane, “The spectrum of apocrine lesions of the breast,” Advances in Anatomic Pathology, vol. 11, no. 1, pp. 1–9, 2004. View at Google Scholar · View at Scopus
  19. C. Leal, R. Henrique, P. Monteiro et al., “Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers,” Human Pathology, vol. 32, no. 5, pp. 487–493, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Guerry, R. A. Erlandson, and P. P. Rosen, “Cystic hypersecretory hyperplasia and cystic hypersecretory duct carcinoma of the breast: pathology, therapy, and follow-up of 39 patients,” Cancer, vol. 61, no. 8, pp. 1611–1620, 1988. View at Google Scholar · View at Scopus
  21. P. P. Rosen and M. Scott, “Cystic hypersecretory duct carcinoma of the breast,” American Journal of Surgical Pathology, vol. 8, no. 1, pp. 31–41, 1984. View at Google Scholar · View at Scopus
  22. I. de Mascarel, G. MacGrogan, S. Mathoulin-Pélissier, I. Soubeyran, V. Picot, and J. M. Coindre, “Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas,” Cancer, vol. 94, no. 8, pp. 2134–2142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. “Breast,” in AJCC Cancer Staging Manual, F. L. Greene, D. L. Page, I. D. Fleming et al., Eds., pp. 221–240, 6th edition, 2002.
  24. T. L. Adamovich and R. M. Simmons, “Ductal carcinoma in situ with microinvasion,” American Journal of Surgery, vol. 186, no. 2, pp. 112–116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. D. L. Page, W. D. Dupont, L. W. Rogers, and M. Landenberger, “Intraductal carcinoma of the breast: follow-up after biopsy only,” Cancer, vol. 49, no. 4, pp. 751–758, 1982. View at Google Scholar · View at Scopus
  26. L. C. Collins, R. M. Tamimi, H. J. Baer, J. L. Connolly, G. A. Colditz, and S. J. Schnitt, “Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the nurses' health study,” Cancer, vol. 103, no. 9, pp. 1778–1784, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Fisher, S. Land, E. Mamounas, J. Dignam, E. R. Fisher, and N. Wolmark, “Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience,” Seminars in Oncology, vol. 28, no. 4, pp. 400–418, 2001. View at Google Scholar · View at Scopus
  28. J. P. Julien, N. Bijker, I. S. Fentiman et al., “Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853,” The Lancet, vol. 355, no. 9203, pp. 528–533, 2000. View at Google Scholar · View at Scopus
  29. N. Bijker, P. Meijnen, J. L. Peterse et al., “Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of european organisation for research and treatment of cancer randomized phase III trial 10853—a study by the EORTC breast cancer cooperative group and EORTC radiotherapy group,” Journal of Clinical Oncology, vol. 24, no. 21, pp. 3381–3387, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Shamliyan, S. Y. Wang, B. A. Virnig, T. M. Tuttle, and R. L. Kane, “Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ,” Journal of the National Cancer Institute Monographs, vol. 2010, no. 41, pp. 121–129, 2010. View at Publisher · View at Google Scholar
  31. M. J. Silverstein, M. D. Lagios, P. H. Craig et al., “A prognostic index for ductal carcinoma in situ of the breast,” Cancer, vol. 77, no. 11, pp. 2267–2274, 1996. View at Google Scholar
  32. M. J. Silverstein, “The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast,” American Journal of Surgery, vol. 186, no. 4, pp. 337–343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. M. J. Silverstein and M. D. Lagios, “Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of Southern California/Van Nuys Prognostic Index,” Journal of the National Cancer Institute, vol. 2010, no. 41, pp. 193–196, 2010. View at Google Scholar · View at Scopus
  34. R. W. Carlson, D. C. Allred, B. O. Anderson et al., “Breast cancer: noninvasive and special situations,” Journal of the National Comprehensive Cancer Network, vol. 8, no. 10, pp. 1182–1207, 2010. View at Google Scholar
  35. D. C. Allred, S. J. Anderson, S. Paik et al., “Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24,” Journal of Clinical Oncology, vol. 30, no. 12, pp. 1268–1273, 2012. View at Google Scholar
  36. A. Grin, F. P. O'Malley, and A. M. Mulligan, “Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy,” American Journal of Surgical Pathology, vol. 33, no. 11, pp. 1615–1623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Otterbach, A. Bànkfalvi, S. Bergner, T. Decker, R. Krech, and W. Boecker, “Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast,” Histopathology, vol. 37, no. 3, pp. 232–240, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. C. M. Perou, T. Sørlie, M. B. Eisen et al., “Molecular portraits of human breast tumours,” Nature, vol. 406, no. 6797, pp. 747–752, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Sørlie, C. M. Perou, R. Tibshirani et al., “Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 19, pp. 10869–10874, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Sørlie, R. Tibshirani, J. Parker et al., “Repeated observation of breast tumor subtypes in independent gene expression data sets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8418–8423, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Vincent-Salomon, C. Lucchesi, N. Gruel et al., “Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast,” Clinical Cancer Research, vol. 14, no. 7, pp. 1956–1965, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Hannemann, A. Velds, J. B. G. Halfwerk, B. Kreike, J. L. Peterse, and M. J. van de Vijver, “Classification of ductal carcinoma in situ by gene expression profiling,” Breast Cancer Research, vol. 8, no. 5, article R61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. S. E. Clark, J. Warwick, R. Carpenter, R. L. Bowen, S. W. Duffy, and J. L. Jones, “Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease,” British Journal of Cancer, vol. 104, no. 1, pp. 120–127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. R. M. Tamimi, H. J. Baer, J. Marotti et al., “Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer,” Breast Cancer Research, vol. 10, no. 4, article R67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. C. A. Livasy, C. M. Perou, G. Karaca et al., “Identification of a basal-like subtype of breast ductal carcinoma in situ,” Human Pathology, vol. 38, no. 2, pp. 197–204, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. M. A. Lopez-Garcia, F. C. Geyer, M. Lacroix-Triki, C. Marchió, and J. S. Reis-Filho, “Breast cancer precursors revisited: molecular features and progression pathways,” Histopathology, vol. 57, no. 2, pp. 171–192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. S. R. Wellings and H. M. Jensen, “On the origin and progression of ductal carcinoma in the human breast,” Journal of the National Cancer Institute, vol. 50, no. 5, pp. 1111–1116, 1973. View at Google Scholar · View at Scopus
  48. S. R. Wellings, H. M. Jensen, and R. G. Marcum, “An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions,” Journal of the National Cancer Institute, vol. 55, no. 2, pp. 231–273, 1975. View at Google Scholar · View at Scopus
  49. T. M. A. Abdel-Fatah, D. G. Powe, Z. Hodi, J. S. Reis-Filho, A. H. S. Lee, and I. O. Ellis, “Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family,” American Journal of Surgical Pathology, vol. 32, no. 4, pp. 513–523, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. P. T. Simpson, J. S. Reis-Filho, T. Gale, and S. R. Lakhani, “Molecular evolution of breat cancer,” Journal of Pathology, vol. 205, no. 2, pp. 248–254, 2005. View at Publisher · View at Google Scholar · View at Scopus